Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,596,439
-
Total 13F shares
-
2,430,438
-
Share change
-
+172,186
-
Total reported value
-
$47,770,863
-
Price per share
-
$19.63
-
Number of holders
-
52
-
Value change
-
+$3,274,459
-
Number of buys
-
27
-
Number of sells
-
17
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2017
As of 31 Dec 2017,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,430,438 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, Claraphi Advisory Network, LLC, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, COHEN & STEERS INC, Invesco Ltd., LPL Financial LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., and Cambridge Investment Research Advisors, Inc..
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.